摘要
目的:探讨细胞凋亡在乳腺癌变过程中的作用及其与细胞增殖以及bcl2、PCNA表达的关系。方法:利用TUNEL法及免疫组化SP法检测54例乳腺癌及27例非癌病变中细胞凋亡指数(AI)以及bcl2、PCNA的表达;同时计算核分裂指数(MI)。结果:“正常”乳腺上皮、增生性导管、原位癌及浸润性癌的AI和MI分别为:010%±012%、031%±043%、041%±021%、074%±056%和002%±005%、001%±016%、022%±017%、057%±035%(P<005);AI与MI呈正相关(r=087,P<001),且随着病变的发展,AI/MI呈下降的趋势。“正常”乳腺上皮、增生性导管、原位癌、浸润性癌中bcl2、PCNA表达率分别为:6842%、6250%、5556%、4889%和2632%、3750%、6667%、8889%;PCNA表达与MI呈正相关(rs=1,P<001)。癌组织中,bcl2高表达者AI显著低于bcl2低表达者。结论:细胞凋亡和细胞增殖均参与乳腺癌变的过程,bcl2在乳腺癌中具有抑凋亡作用,且bcl2表达?
Purpose To explore the role of apoptosis in breast carcinogenesis and the relationship between apoptosis and cell proliferation and bcl 2、PCNA expression. Methods The methods of TUNEL and immunohistochemical S P were used to investigate the occurence of apoptosis and bcl 2、PCNA expression in 81 female breast carcinomas and 27 cases noncancer lesions. Apoptosis index( AI ) and mitotic index ( MI ) were calculated in all of the tissues. Results AI and MI in normal breast epithelial tissues, hyperplastic ductal tissues, carcinomas in situ and invasive ductal carcinoma tissues were 0 10%±0 12%、0 31%±0 43%、0 41%±0 21%、0 74%±0 56% and 0 02%±0 05%、0 01%±0 16%、0 22%±0 17%、0 57%±0 35% respectively ( P <0 05). There was a significant direct correlation between them ( r =0 87, P <0 01). The incidences of bcl 2 and PCNA positivity in normal breast epithelial tissues, hyperplastic ductal tissues, carcinomas in situ and invasive carcinoma tissues were 68 42%、62 50%、55 56%、48 89% and 26 32%、37 50%、66 67%、88 89% respectively. Breast carcinomas expressing bcl 2 were significantly more likely to have low AI . Conclusion Both apoptosis and cell proliferation take part in breast carcinogenesis. Bcl 2 is responsible for inhibition of apoptosis in breast carcinomas, and the loss of bcl 2 expression is a relatively late event in the progression of breast carcinoma.
出处
《临床与实验病理学杂志》
CAS
CSCD
1999年第2期99-102,共4页
Chinese Journal of Clinical and Experimental Pathology
关键词
乳腺癌
癌前病变
BCL-2基因
PCNA
细胞凋亡
breast neoplasms
apoptosis
precancerous condition
cell proliferation
bcl 2 oncogene
proliferation cell nuclear antigen